⌘K

Home/Filings/4/0000905718-21-000586

4//SEC Filing

Gudin Jeffrey 4

Accession 0000905718-21-000586

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Apr 8, 8:00 PM ET

Accepted

Apr 9, 5:25 PM ET

Size

5.3 KB

Accession

0000905718-21-000586

Insider Transaction Report

Form 4

Period: 2021-04-07

Virpax Pharmaceuticals, Inc.VRPX

DirectorChief Medical Officer

Transactions

Award
Stock Option (right to buy)
2021-04-07+50,000→ 50,000 total
Exercise: $4.62Exp: 2031-04-07→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The option vests in three equal annual installments commencing on April 7, 2022.

Documents

1 file

4
gudin_fm4april72021.xmlPrimary

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001818449

Filing Metadata

Form type: 4
Filed: Apr 8, 8:00 PM ET
Accepted: Apr 9, 5:25 PM ET
Size: 5.3 KB

View on SEC.gov